Corporate ActionOct 8, 2026, 12:16 PM
China SXT Pharmaceuticals Raises $12M in Direct Offering
AI Summary
China SXT Pharmaceuticals, Inc. announced a registered direct offering of approximately $12 million. The offering consists of 8,000,000 Class A ordinary shares (or pre-funded warrants) at a purchase price of $1.50 per share, along with 8,000,000 warrants exercisable at $2.75 per share. The company also disclosed a typographical error correction regarding the warrant exercise price in a prior press release. The offering is expected to close around October 9, 2026.
Key Highlights
- China SXT Pharmaceuticals announces registered direct offering of 8,000,000 shares at $1.50 each.
- The offering includes 8,000,000 warrants with an exercise price of $2.75 per share.
- Gross proceeds from the offering are expected to be approximately $12 million.
- Investors have an additional purchase right to acquire up to $12 million of securities within 30 days.
- The offering is expected to close on or about October 9, 2026.
Price Impact
More from SXTC